ArticleFrontiers in nephrology2023

Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy.

Laetitia Jacquot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.